在放射性瘤学中优化同行评审回合:一个范围审查
Jessica Zhang1, Conrad Bayley2,3, Marcus Vaska4
1Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Frontiers in oncology
|February 23, 2026
概括
在放射性瘤学 (RO) 中,同行评审 (PR) 轮是至关重要的,但耗时. 这次审查发现对优化公关效率的研究有限,强调需要自动化和诸如检查清单等工具来改善工作流程和患者安全.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 医疗保健管理的管理
背景情况:
- 同行评审 (PR) 轮在放射瘤学 (RO) 中对于质量保证和沟通至关重要.
- 低效率,包括时间限制和不平衡的贡献,往往会阻碍有效的公关.
- 优化公关流程对于维持放射治疗 (RT) 规划的高标准至关重要.
研究的目的:
- 进行旨在提高公关效率和RO的经验的新工具和流程的范围审查.
- 确定学术医疗中心内部优化公关的当前策略和差距.
主要方法:
- 在六个主要数据库和灰色文献中进行了全面的搜索,得到了8,955个引用.
- 如果这些研究专注于RT中的公关流程,并解决了效率问题,就包括了这些研究,但不包括基于纸张的比较.
- 选择了12项研究进行分析,检查了结构格式,自动化和检查清单.
主要成果:
- 十一项研究探讨了结构格式,以改善公关促进.
- 五项研究讨论了自动化工具的使用,两项研究评估了检查清单.
- 只有一半的研究报告了时间负担,只有有限的证据表明实施后效率的积极变化.
结论:
- 有一个显著缺乏研究的创新方法,以优化公关轮在RO.
- 整合自动化和检查清单等工具对于简化公关和减少效率低下至关重要.
- 未来的研究应该专注于开发和评估节省时间的战略,以实现RO中可持续和有影响力的公关.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K